BioNTech SE (0A3M) Income Statement
6 Followers
BioNTech SE Income Statement
Last quarter (Q3 2026), BioNTech SE's total revenue was €1.29B, a decrease of 15.12% from the same quarter last year. In Q3, BioNTech SE's net income was €184.50M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 2.76B | € 2.75B | € 3.82B | € 17.31B | € 18.98B | |
| € 2.14B | € 2.21B | € 3.22B | € 14.32B | € 16.07B | |
| € 2.76B | € 3.52B | € 2.53B | € 1.67B | € 781.40M | |
| Depreciation and Amortization | € 367.69M | € 298.00M | € 183.40M | € 123.30M | € 75.20M |
| € -628.00M | € -367.10M | € 1.38B | € 13.10B | € 15.00B | |
| € -623.87M | € -1.31B | € 690.40M | € 12.64B | € 15.28B | |
| € -385.46M | € 636.60M | € 495.70M | € 311.40M | € -237.40M | |
| € -1.01B | € -677.70M | € 1.19B | € 12.95B | € 15.05B | |
| € -1.09B | € -665.30M | € 930.30M | € 9.43B | € 10.29B | |
| Per Share Metrics | |||||
| Basic EPS | € -4.51 | € -2.77 | € 3.87 | € 38.08 | € 43.87 |
| Diluted EPS | € -4.51 | € -2.77 | € 3.83 | € 37.09 | € 41.21 |
| Weighted Average Shares Outstanding | 241.70M | 240.40M | 240.60M | 243.30M | 244.00M |
| Weighted Average Shares Outstanding (Diluted) | 241.70M | 240.40M | 242.70M | 249.80M | 259.70M |
Currency in EUR
